Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGB | P11216 | 8/20 | 0.44 |
| ▸ | PYGL | P06737 | 3/20 | 0.44 |
| ▸ | PYGM | P11217 | 2/20 | 0.44 |
| ▸ | SLC5A1 | P13866 | 2/20 | 0.38 |
| ▸ | SLC5A2 | P31639 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18890762 | 1.00 | PYGB (0.44) | PYGBPYGLPYGMSLC5A1SLC5A2 | |
| SCHEMBL14502562 | 1.00 | PYGB (0.44) | PYGBPYGLPYGMSLC5A1SLC5A2 | |
| SCHEMBL19226203 | 1.00 | PYGB (0.44) | PYGBPYGLPYGMSLC5A1SLC5A2 | |
| SCHEMBL14502563 | 1.00 | PYGB (0.44) | PYGBPYGLPYGMSLC5A1SLC5A2 | |
| SCHEMBL14502578 | 1.00 | PYGB (0.44) | PYGBPYGLPYGMSLC5A1SLC5A2 | |
| SCHEMBL24924778 | 1.00 | PYGB (0.44) | PYGBPYGLPYGMSLC5A1SLC5A2 | |
| SCHEMBL13787598 | 0.93 | PYGB (0.38) | PYGBPYGLPYGMSLC5A1SLC5A2 | |
| SCHEMBL12929272 | 0.93 | PYGB (0.38) | PYGBPYGLPYGMSLC5A1SLC5A2 | |
| SCHEMBL12899851 | 0.93 | PYGB (0.38) | PYGBPYGLPYGMSLC5A1SLC5A2 | |
| SCHEMBL16812689 | 0.80 | PYGB (0.43) | PYGBPYGLPYGM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090318675-A1 | NOVEL GEM-DIFLUORINATED C-GLYCOSIDE COMPOUNDS DERIVED FROM PODOPHYLLOTOXIN, THEIR PREPARATION AND THEIR APPLICATIONS | SUNSHINE BIOPHARMA INC. (CA) | 2009-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090318675-A1 | NOVEL GEM-DIFLUORINATED C-GLYCOSIDE COMPOUNDS DERIVED FROM PODOPHYLLOTOXIN, THEIR PREPARATION AND THEIR APPLICATIONS | GLRA3, GMNN, B3GAT3 | PYGB 1099/4885PYGL 1504/4885PYGM 2194/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.